World Journal of Surgery

, Volume 33, Issue 9, pp 1822–1829 | Cite as

Candida Isolation in Patients Hospitalized on a Surgical Ward: Significance and Mortality-Related Factors

  • J. Marchena-GomezEmail author
  • T. Saez-Guzman
  • M. Hemmersbach-Miller
  • A. Conde-Martel
  • V. Morales-Leon
  • A. Bordes-Benitez
  • M. A. Acosta-Merida



Infections caused by Candida are an emerging pathology on surgical wards. The aim of the present study was to evaluate the incidence, characteristics, and predictive factors of mortality in patients colonized and/or infected by Candida spp. in this setting.


A consecutive series of 105 patients hospitalized on a general surgery ward between 2000 and 2004 were included, and 118 positive cultures for Candida were identified. The variables age, sex, previous medical history, current disease, anemia, ICU stay, type and localization of the microorganism, need for parenteral nutrition, and transfusions were recorded. The primary outcome was in-hospital mortality. A univariate analysis was performed to determine which of these variables were associated with mortality. With a logistic regression model, independent prognostic factors of mortality were determined.


The prevalence of patients colonized and/or infected by Candida on our surgical ward was 0.98% (CI 95%: 0.79–1.17), and the incidence was 49 cases per 1,000 patient-years. Of the 105 patients in this series, 56 were men (53%) and 49 women (47%); the mean age was 63.8 years (SD ± 15.7). Twelve patients (11.4%) had candidemia. Crude mortality was 23% (24 patients), whereas the mortality attributable to candidemia was 25% (3/12 cases). Anemia (p = 0.001); transfusions (p = 0.003), and an ICU stay (p = 0.002) were associated with mortality. Candidemia was associated with neoplasms (p = 0.02) and the infection caused by Candida parapsilosis (p = 0.04). The only independent factor related to mortality was the anemia (p = 0.028; Odds Ratio: 6.43; 95% CI: 1.23–33.73).


Colonization and/or infection by Candida spp. in non-ICU hospitalized surgical patients implies a relative high mortality. Anemia is an independent factor for mortality.


Antifungal Therapy Caspofungin Invasive Fungal Infection Antifungal Drug Fungal Colonization 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. 1.
    Luzzati R, Amalfitano G, Lazzarini L et al (2000) Nosocomial candidemia in non-neutropenic patients at an Italian tertiary care hospital. Eur J Clin Microbiol Infect Dis 19:602–607PubMedCrossRefGoogle Scholar
  2. 2.
    Leon C, Alvarez-Lerma F, Ruiz-Santana S et al (2009) Fungal colonization and/or infection in non-neutropenic critically ill patients: results of the EPCAN observational study. Eur J Clin Microbiol Infect Dis 28:233–242PubMedCrossRefGoogle Scholar
  3. 3.
    Olaechea PM, Palomar M, Leon-Gil C et al (2004) Economic impact of Candida colonization and Candida infection in the critically ill patient. Eur J Clin Microbiol Infect Dis 23:323–330PubMedCrossRefGoogle Scholar
  4. 4.
    Zaoutis TE, Argon J, Chu J et al (2005) The epidemiology and attributable outcomes of candidemia in adults and children hospitalized in the United States: a propensity analysis. Clin Infect Dis 41:1232–1239PubMedCrossRefGoogle Scholar
  5. 5.
    McKinnon PS, Goff DA, Kern JW et al (2001) Temporal assessment of Candida risk factors in the surgical intensive care unit. Arch Surg 136:1401–1408PubMedCrossRefGoogle Scholar
  6. 6.
    Chen S, Slavin M, Nguyen Q et al (2006) Active surveillance for candidemia, Australia. Emerg Infect Dis 12:1508–1516PubMedGoogle Scholar
  7. 7.
    Leone M, Albanese J, Antonini F et al (2003) Long-term epidemiological survey of Candida species: comparison of isolates found in an intensive care unit and in conventional wards. J Hosp Infect 55:169–174PubMedCrossRefGoogle Scholar
  8. 8.
    Nguyen MH, Peacock JE Jr, Morris AJ et al (1996) The changing face of candidemia: emergence of non-Candida albicans species and antifungal resistance. Am J Med 100:617–623PubMedCrossRefGoogle Scholar
  9. 9.
    Presterl E, Daxbock F, Graninger W et al (2007) Changing pattern of candidaemia 2001–2006 and use of antifungal therapy at the University Hospital of Vienna, Austria. Clin Microbiol Infect 13:1072–1076PubMedCrossRefGoogle Scholar
  10. 10.
    Charles PE, Doise JM, Quenot JP et al (2003) Candidemia in critically ill patients: difference of outcome between medical and surgical patients. Intensive Care Med 29:2162–2169PubMedCrossRefGoogle Scholar
  11. 11.
    Pittet D, Monod M, Suter PM et al (1994) Candida colonization and subsequent infections in critically ill surgical patients. Ann Surg 220:751–758PubMedCrossRefGoogle Scholar
  12. 12.
    Lipsett PA (2006) Surgical critical care: fungal infections in surgical patients. Crit Care Med 34:S215–S224PubMedCrossRefGoogle Scholar
  13. 13.
    Dimopoulos G, Ntziora F, Rachiotis G et al (2008) Candida albicans versus non-albicans intensive care unit-acquired bloodstream infections: differences in risk factors and outcome. Anesth Analg 106:523–529PubMedCrossRefGoogle Scholar
  14. 14.
    Toya SP, Schraufnagel DE, Tzelepis GE (2007) Candiduria in intensive care units: association with heavy colonization and candidaemia. J Hosp Infect 66:201–206PubMedCrossRefGoogle Scholar
  15. 15.
    Wey SB, Mori M, Pfaller MA et al (1989) Risk factors for hospital-acquired candidemia. A matched case-control study. Arch Intern Med 149:2349–2353PubMedCrossRefGoogle Scholar
  16. 16.
    Blot S, Dimopoulos G, Rello J et al (2008) Is Candida really a threat in the ICU? Curr Opin Crit Care 14:600–604PubMedCrossRefGoogle Scholar
  17. 17.
    Sandven P, Qvist H, Skovlund E et al (2002) Significance of Candida recovered from intraoperative specimens in patients with intra-abdominal perforations. Crit Care Med 30:541–547PubMedCrossRefGoogle Scholar
  18. 18.
    Blot SI, Vandewoude KH, De Waele JJ (2007) Candida peritonitis. Curr Opin Crit Care 13:195–199PubMedCrossRefGoogle Scholar
  19. 19.
    Montravers P, Dupont H, Gauzit R et al (2006) Candida as a risk factor for mortality in peritonitis. Crit Care Med 34:646–652PubMedCrossRefGoogle Scholar
  20. 20.
    Hughes MG, Evans HL, Lightfoot L et al (2003) Does prior transfusion worsen outcomes from infection in surgical patients? Surg Infect (Larchmt) 4:335–343CrossRefGoogle Scholar
  21. 21.
    Falagas ME, Apostolou KE, Pappas VD (2006) Attributable mortality of candidemia: a systematic review of matched cohort and case-control studies. Eur J Clin Microbiol Infect Dis 25:419–425PubMedCrossRefGoogle Scholar
  22. 22.
    Parkins MD, Sabuda DM, Elsayed S et al (2007) Adequacy of empirical antifungal therapy and effect on outcome among patients with invasive Candida species infections. J Antimicrob Chemother 60:613–618PubMedCrossRefGoogle Scholar
  23. 23.
    Leon C, Ruiz-Santana S, Saavedra P et al (2006) A bedside scoring system (“Candida score”) for early antifungal treatment in nonneutropenic critically ill patients with Candida colonization. Crit Care Med 34:730–737PubMedCrossRefGoogle Scholar

Copyright information

© Société Internationale de Chirurgie 2009

Authors and Affiliations

  • J. Marchena-Gomez
    • 1
    • 2
    Email author
  • T. Saez-Guzman
    • 1
  • M. Hemmersbach-Miller
    • 3
  • A. Conde-Martel
    • 3
  • V. Morales-Leon
    • 4
  • A. Bordes-Benitez
    • 5
  • M. A. Acosta-Merida
    • 1
  1. 1.Department of SurgeryUniversity Hospital of Gran Canaria “Dr. Negrin”Las Palmas de Gran CanariaSpain
  2. 2.Las Palmas de Gran CanariaSpain
  3. 3.Department of Internal MedicineUniversity Hospital of Gran Canaria “Dr. Negrin”Las Palmas de Gran CanariaSpain
  4. 4.Department of PharmacyUniversity Hospital of Gran Canaria “Dr. Negrin”Las Palmas de Gran CanariaSpain
  5. 5.Department of MicrobiologyUniversity Hospital of Gran Canaria “Dr. Negrin”Las Palmas de Gran CanariaSpain

Personalised recommendations